Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 09 - 02 symbols : Pstx save search
P-PSMA-101 is a High-Tscm Autologous CAR-T Targeting PSMA Producing Exceptionally Deep and Durable Responses in Castration-Resistant Metastatic Prostate Cancer (mCRPC)
Published: 2021-09-02 (Crawled : 16:00) - poseida.com
PSTX | $2.03 -16.46% -19.7% 1.4M
|
Health Technology
|
| O: 3.27%
H: 0.0%
C: -4.98%
prostate cancer car-t cancer
Developing piggyBac Systems “Off-the-Shelf” CAR-T Cells for Bone Marrow Transplant Conditioning
Published: 2021-09-02 (Crawled : 13:00) - poseida.com
PSTX | $2.03 -16.46% -19.7% 1.4M
|
Health Technology
|
| O: 3.27%
H: 0.0%
C: -4.98%
bone car-t t-cell
Poseida’s CAR-T Cell Therapy for Prostate Cancer Shows Promising Durable Response in Phase 1
Published: 2021-09-02 (Crawled : 01:00) - poseida.com
PSTX | $2.03 -16.46% -19.7% 1.4M
|
Health Technology
|
| O: 3.27%
H: 0.0%
C: -4.98%
prostate cancer phase 1 therapy car-t cancer phase 2 phase 3 response t-cell
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M
|
Electronic Technology
VIAO | $0.265 -13.96% 35.85% 960K
|
Electronic Technology
JAGX | $0.178 49.83% 33.26% 600M
|
Health Technology
SXTC | $1.68 43.59% 30.36% 34M
|
Health Technology
DYNT | $0.531 43.36% 30.24% 22M
|
Health Technology
KA | $0.4796 41.06% 29.11% 5.3M
|
Manufacturing
PALI | $5.86 40.87% 29.01% 29M
|
Manufacturing
CLNN | $0.319 -3.74% 28.75% 6.3M
|
BSGM | $1.52 38.18% 27.63% 3.3M
|
Health Technology
MCBC | $13.67 37.66% 27.36% 2.2M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.